Literature DB >> 36267924

Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes.

Maryam Hassanzad1, Sabereh Tashayoie-Nejad1, Mohammadreza Boloursaz1, Seyed Alireza Mahdaviani1, Nooshin Baghaie1, Hosseinali Ghaffaripour1, Farahnaz Aghahosseini1, Zargham Hossein Ahmadi2, Tahereh Parsa3, Behrooz Farzanegan4, Atefeh Fakharian5, Seyed Javad Seyedi6, Ali Akbar Velayati7.   

Abstract

Background: Pulmonary Alveolar Proteinosis (PAP) is an uncommon pulmonary disease characterized by the accumulation of surfactant composed of proteins and lipids due to disruption of surfactant clearance by alveolar macrophages. The current standard treatment is lung lavage. There are no specific criteria for lavage, but in case of observing these signs it is recommended to perform lavage for the patient: progressive respiratory failure, no labored breathing at rest, and drop in oxygen level during activity (>5%). Materials and
Methods: In this study, patients with PAP admitted to Pediatric ward of Masih Daneshvari Hospital were studied. The required data were collected including the patient's demographic data, clinical signs and radiographic data, the number of admissions, the age of diagnosis, detection and treatment methods, number of lavage, current condition of the patient, and in case of death, the cause of death.
Results: In this study, 17 patients with PAP who were admitted during the past 15 years were examined; among which 7 patients were boys (41.2%) and 10 were girls (58.8%). The mean age of population was 11.79±7.21 years. Transbronchial Lung Biopsy (TBLB) (47.1%) and open lung biopsy (52.9%) were used for diagnosis of patients. Lung lavage was used to treat patients, 15 of whom were treated by this method. Five of the patients died because of their serious conditions.
Conclusion: Therapy method in the present study was lavage for both lungs, and it was performed for all patients except for two patients due to their anatomical complications. This method is still considered as the gold standard for PAP. Considering the findings from previous studies and the present study, it seems that Whole Lung Lavage (WLL) was fruitful for patients who had the indication for using this therapy and it played a significant role in improving the prognosis of patients. Besides, it is recommended to do follow-up regularly in order to have more therapeutic efficacy and increased patient longevity. Copyright
© 2021 National Research Institute of Tuberculosis and Lung Disease.

Entities:  

Keywords:  Diagnosis; Outcome; Pulmonary alveolar Proteinosis

Year:  2021        PMID: 36267924      PMCID: PMC9577214     

Source DB:  PubMed          Journal:  Tanaffos        ISSN: 1735-0344


  14 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  R Borie; C Danel; M-P Debray; C Taille; M-C Dombret; M Aubier; R Epaud; B Crestani
Journal:  Eur Respir Rev       Date:  2011-06

Review 2.  Pulmonary alveolar proteinosis in children.

Authors:  Jacques de Blic
Journal:  Paediatr Respir Rev       Date:  2004-12       Impact factor: 2.726

3.  Whole-lung lavage for pediatric patients with pulmonary alveolar proteinosis.

Authors:  Leigh Ann DiFusco; Raj K Verma
Journal:  AORN J       Date:  2013-07       Impact factor: 0.676

4.  Diagnosis of pediatric pulmonary tuberculosis with special reference to polymerase chain reaction based nucleic acid amplification test.

Authors:  Shreshtha Tiwari; Gita Nataraj; Swapna Kanade; Preeti Mehta
Journal:  Int J Mycobacteriol       Date:  2015-01-23

5.  Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.

Authors:  Shilan Mohammadi; Soheila Khalilzadeh; Koroush Goudarzipour; Maryam Hassanzad; Alireza Mahdaviani; Nahid Aarabi; Mihan Pourabdollah; Naseh Sigari
Journal:  Med Mycol       Date:  2015-07-30       Impact factor: 4.076

Review 6.  Pulmonary alveolar proteinosis: progress in the first 44 years.

Authors:  John F Seymour; Jeffrey J Presneill
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

Review 7.  Pulmonary Alveolar Proteinosis Syndrome.

Authors:  Takuji Suzuki; Bruce C Trapnell
Journal:  Clin Chest Med       Date:  2016-06-17       Impact factor: 2.878

8.  Pulmonary alveolar proteinosis in children on La Réunion Island: a new inherited disorder?

Authors:  Laurent Enaud; Alice Hadchouel; Aurore Coulomb; Laureline Berteloot; Florence Lacaille; Liliane Boccon-Gibod; Vincent Boulay; Françoise Darcel; Matthias Griese; Mélinée Linard; Malek Louha; Michel Renouil; Jean-Pierre Rivière; Bruno Toupance; Virginie Verkarre; Christophe Delacourt; Jacques de Blic
Journal:  Orphanet J Rare Dis       Date:  2014-06-14       Impact factor: 4.123

9.  Whole lung lavage of nine children with pulmonary alveolar proteinosis: experience in a tertiary lung center.

Authors:  Radpay Badiozaman; Parsa Tahereh; Dabir Shideh; Boloursaz Mohammadreza; Arbab Ahmadreza; Tabatabaei Seyyedahmad
Journal:  Iran J Pediatr       Date:  2013-02       Impact factor: 0.364

10.  Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures.

Authors:  Ilaria Campo; Maurizio Luisetti; Matthias Griese; Bruce C Trapnell; Francesco Bonella; Jan Grutters; Koh Nakata; Coline H M Van Moorsel; Ulrich Costabel; Vincent Cottin; Toshio Ichiwata; Yoshikazu Inoue; Antonio Braschi; Giacomo Bonizzoni; Giorgio A Iotti; Carmine Tinelli; Giuseppe Rodi
Journal:  Orphanet J Rare Dis       Date:  2016-08-31       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.